Login / Signup

Cognitive Function of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate.

David R CoghillTobias BanaschewskiCaleb BlissBrigitte RobertsonAlessandro Zuddas
Published in: CNS drugs (2019)
NCT01328756.
Keyphrases
  • open label
  • squamous cell carcinoma
  • randomized controlled trial
  • phase ii
  • study protocol
  • rectal cancer
  • locally advanced